Search for: "ABBOTT v. ABBOTT" Results 2001 - 2020 of 2,570
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Dec 2009, 4:43 pm by Tom Goldstein
The question presented is whether the exception applies to state and local reports and investigations, or is limited to those by the federal government. ------- Title: Abbott v. [read post]
16 Jul 2019, 8:05 pm by Sandy Levinson
Greg Abbott, that is suggesting the need for serious reform. [read post]
15 Sep 2011, 5:00 am by Bexis
Abbott Laboratories, 447 F.3d 861, 867 [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
21 Apr 2015, 4:49 am by Jim Singer
Abbott Labs, 124 F.3d 1419, 1426 (Fed. [read post]
4 Jul 2015, 4:36 pm by INFORRM
Landmark defamation judgments, still regularly cited and applied, involve politicians such as Tom Uren, Bob Hawke, Jim Cairns, Tony Abbott and Peter Costello as plaintiffs. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
14 Jun 2007, 6:55 am
Abbott Laboratories, 745 A.2d 1174 (N.J. 2000). [read post]